New Delhi, Oct. 19 -- Anti-cancer drugs are set to become cheaper in India from November 9. The Ministry of Chemicals and Fertilizers said in a statement that as many as 137 cancer drugs have been included in the Trade Margin Rationalisation (TMR), in a bid to make treatment more affordable.

With the latest notification, the medicines, which include immunotherapy drugs used for treating over 20 types of cancer, as well as for breast, prostate, colon, ovarian and cervical cancer, will be subject to the price changes from November 9.

"The MRP of widely used anti-cancer drugs such as Pembrolizumab, Durvalumab and Osimertinib is expected become more accessible for cancer patients," the ministry said in a press release.

The latest decision ...